September 23, 2017

Gender Matters: Why Afib Is More Fatal for Women

EP Lab Digest recently published Gender Matters: Why Afib Is More Fatal for Women, authored by StopAfib.org founder Mellanie True Hills. In it, she discussed the research into why atrial fibrillation and afib-related strokes are more deadly for women and what can be done. Topics include: Stroke and bleeding risk assessment tools, including CHADS2, CHA2DS2-VASc, […]

New Expert Recommendations on Assessing Atrial Fibrillation Stroke and Bleeding Risk for Appropriate Anticoagulation

The Atrial Fibrillation Optimal Treatment Task Force, led by the Alliance for Aging Research, has just released a consensus statement developed by a group of leading afib stroke prevention experts. We at StopAfib.org are proud to have been part of the development of this consensus statement, which recommends a process for assessing afib stroke and […]

Are you at risk of bleeding from anticoagulants Coumadin or warfarin: New “HAS-BLED” tool assesses risk for those with atrial fibrillation

One of the most common questions we get centers around the use of anticoagulant drugs—either the brand drug, Coumadin, or the generic version, warfarin—and whether or not an atrial fibrillation patient should be on them. Anticoagulants decrease stroke risk, but can also increase bleeding risk. How do you sort it all out? It’s just as […]